Home LiteratureArticle Details
PMID: 10733469 Published · ppublish English Journal Article Review

Cytokines and systemic lupus erythematosus.

Annals of the rheumatic diseases ·Vol. 59 ·No. 4 ·2000-04-00 ·Pages 243-51

Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA

Abstract

暂无摘要

MeSH Terms
Autoantibodies/immunology Autoimmune Diseases/immunology Cytokines/immunology,physiology Humans Interferon-gamma/physiology Interleukin-10/physiology Interleukins/immunology,physiology Lupus Erythematosus, Systemic/immunology Tumor Necrosis Factor-alpha/physiology
Chemicals
Autoantibodies Cytokines Interleukins Tumor Necrosis Factor-alpha Interleukin-10 Interferon-gamma
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Dean G S
Centre for Rheumatology/ Bloomsbury Rheumatology Unit, Department of Medicine, University College, London, UK.
Tyrrell-Price J
Crawley E
Isenberg D A
References (75)
75 references, click to expand
  1. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    J Immunol. 1998 Mar 1;160(5):2539-45 PMID: 9498800
  2. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes.
    Cytokine. 1998 Feb;10(2):140-7 PMID: 9512904
  3. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.
    Arthritis Rheum. 1998 Apr;41(4):596-602 PMID: 9550468
  4. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
    J Immunol. 1998 Apr 15;160(8):3713-8 PMID: 9558072
  5. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Arthritis Rheum. 1998 May;41(5):838-44 PMID: 9588735
  6. Renal expression of IL-6 and TNFalpha genes in lupus nephritis.
    Lupus. 1998;7(3):154-8 PMID: 9607638
  7. Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus.
    Clin Exp Immunol. 1992 Aug;89(2):251-4 PMID: 1638768
  8. Interleukin-10.
    Curr Opin Immunol. 1992 Jun;4(3):314-20 PMID: 1418711
  9. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.
    J Exp Med. 1993 Feb 1;177(2):557-60 PMID: 8426126
  10. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha.
    Clin Exp Immunol. 1993 Apr;92(1):14-8 PMID: 8096802
  11. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
    Kidney Int Suppl. 1993 Jan;39:S71-5 PMID: 8468929
  12. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
    J Exp Med. 1993 May 1;177(5):1367-81 PMID: 8478612
  13. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
    Lupus. 1992 Feb;1(2):111-7 PMID: 1301962
  14. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.
    Hum Mol Genet. 1992 Aug;1(5):353 PMID: 1363876
  15. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
    Clin Exp Immunol. 1993 Jul;93(1):39-44 PMID: 8100746
  16. Interleukin-6 receptor blockage ameliorates murine lupus nephritis.
    J Am Soc Nephrol. 1993 Jul;4(1):58-61 PMID: 8400070
  17. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    J Immunol. 1993 Dec 1;151(11):6525-34 PMID: 8245483
  18. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus.
    Arthritis Rheum. 1998 Jun;41(6):1090-5 PMID: 9627019
  19. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
    Clin Exp Rheumatol. 1998 May-Jun;16(3):283-8 PMID: 9631750
  20. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus.
    Clin Rheumatol. 1998;17(2):110-4 PMID: 9641506
  21. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Cas Lek Cesk. 1998 May 4;137(9):271-5 PMID: 9650355
  22. Infectious tolerance.
    Curr Opin Immunol. 1998 Oct;10(5):518-24 PMID: 9794831
  23. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).
    Clin Exp Immunol. 1999 Jan;115(1):189-95 PMID: 9933441
  24. Circulating interleukin-16 in systemic lupus erythematosus.
    Br J Rheumatol. 1998 Dec;37(12):1334-7 PMID: 9973160
  25. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
    Clin Rheumatol. 1999;18(1):17-22 PMID: 10088943
  26. The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity.
    Lupus. 1999;8(2):90-4 PMID: 10192501
  27. Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus.
    Arthritis Rheum. 1999 Sep;42(9):2017-8 PMID: 10513824
  28. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.
    Springer Semin Immunopathol. 1994;16(2-3):181-200 PMID: 7716704
  29. Serum antibodies to human fetal antigens in patients with systemic lupus erythematosus (SLE).
    J Immunol. 1980 Mar;124(3):1154-9 PMID: 6153671
  30. Responsiveness of autoimmune and normal mice to nucleic acid antigens.
    J Immunol. 1984 Feb;132(2):872-6 PMID: 6690621
  31. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
    J Exp Med. 1987 Nov 1;166(5):1229-44 PMID: 2960769
  32. In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon.
    J Rheumatol. 1988 Mar;15(3):438-44 PMID: 3132556
  33. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
    J Immunol. 1988 Aug 1;141(3):827-33 PMID: 3135313
  34. Heterogeneity of cytokine secretion patterns and functions of helper T cells.
    Adv Immunol. 1989;46:111-47 PMID: 2528896
  35. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.
    J Immunol. 1989 Dec 1;143(11):3470-5 PMID: 2584702
  36. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233-7 PMID: 2105500
  37. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
    J Dermatol Sci. 1990 May;1(3):207-15 PMID: 2085508
  38. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
    J Rheumatol. 1991 Mar;18(3):368-72 PMID: 1906936
  39. Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).
    Clin Exp Immunol. 1991 Sep;85(3):386-91 PMID: 1893618
  40. Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production.
    Clin Immunol Immunopathol. 1992 Jun;63(3):245-51 PMID: 1623645
  41. A polymorphic variation in a putative regulation box of the TNFA promoter region.
    Immunogenetics. 1994;39(2):150-4 PMID: 7903959
  42. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
    J Immunol. 1994 Apr 1;152(7):3685-92 PMID: 8144943
  43. Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1-stimulated endothelium.
    Int Arch Allergy Immunol. 1994;104(2):131-6 PMID: 8199456
  44. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis.
    Blood. 1995 Jan 15;85(2):487-94 PMID: 7812003
  45. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
    J Exp Med. 1995 Mar 1;181(3):839-44 PMID: 7869046
  46. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    J Med. 1997;28(1-2):99-107 PMID: 9249616
  47. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.
    Arthritis Rheum. 1997 Aug;40(8):1429-35 PMID: 9259422
  48. Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans.
    Lupus. 1997;6(7):603-9 PMID: 9302664
  49. The CD40 ligand expressed by human B cells costimulates B cell responses.
    J Immunol. 1995 May 15;154(10):4996-5010 PMID: 7537298
  50. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
    Cytokine. 1995 Jan;7(1):1-7 PMID: 7749063
  51. Interleukin-6 expression in the skin of patients with lupus erythematosus.
    Exp Dermatol. 1995 Feb;4(1):52-7 PMID: 7757333
  52. Frequency of lupus in people of African origin.
    Lupus. 1995 Jun;4(3):176-8 PMID: 7655486
  53. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.
    Lupus. 1995 Oct;4(5):393-5 PMID: 8563734
  54. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    J Immunol. 1996 Apr 15;156(8):2964-71 PMID: 8609417
  55. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    J Clin Invest. 1996 May 1;97(9):2063-73 PMID: 8621796
  56. Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline.
    J Cardiovasc Pharmacol. 1995;25 Suppl 2:S80-4 PMID: 8699868
  57. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity.
    Lupus. 1996 Apr;5(2):139-45 PMID: 8743127
  58. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis.
    J Clin Immunol. 1996 Jul;16(4):198-207 PMID: 8840221
  59. TNF microsatellites in systemic lupus erythematosus-a high frequency of the TNFabc 2-3-1 haplotype in multicase SLE families.
    Lupus. 1996 Dec;5(6):618-22 PMID: 9116707
  60. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    J Rheumatol. 1997 Feb;24(2):303-8 PMID: 9034987
  61. An investigation of polymorphism in the interleukin-10 gene promoter.
    Eur J Immunogenet. 1997 Feb;24(1):1-8 PMID: 9043871
  62. Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE.
    J Rheumatol. 1997 Mar;24(3):489-95 PMID: 9058654
  63. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE.
    Lupus. 1997;6(2):175-80 PMID: 9061666
  64. [Cytokines and lupus].
    Ann Med Interne (Paris). 1996;147(7):480-4 PMID: 9092358
  65. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9 PMID: 9096369
  66. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus.
    Tissue Antigens. 1997 Mar;49(3 Pt 1):222-7 PMID: 9098928
  67. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Clin Exp Immunol. 1996 Jun;104(3):446-53 PMID: 9099929
  68. Genetic influence on cytokine production and fatal meningococcal disease.
    Lancet. 1997 Jan 18;349(9046):170-3 PMID: 9111542
  69. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus.
    Br J Rheumatol. 1997 Feb;36(2):190-3 PMID: 9133927
  70. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
    Immunogenetics. 1997;46(2):120-8 PMID: 9162098
  71. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus.
    Tissue Antigens. 1997 Jun;49(6):635-9 PMID: 9234486
  72. The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity.
    Immunol Today. 1997 Nov;18(11):538-42 PMID: 9386350
  73. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    J Clin Invest. 1997 Nov 15;100(10):2622-33 PMID: 9366578
  74. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.
    J Rheumatol. 1997 Dec;24(12):2314-7 PMID: 9415634
  75. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus.
    Br J Rheumatol. 1997 Dec;36(12):1283-9 PMID: 9448589
Article Info
Journal
Annals of the rheumatic diseases
Abbr.
Ann Rheum Dis
ISSN
0003-4967
DOI
10.1136/ard.59.4.243
Published
2000-04-00
Pages
243-51
Language
English
Region
England
NLM ID
0372355
PMCID
PMC1753117
Subset
IM
External Links
PubMed source DOI: 10.1136/ard.59.4.243 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2